Next-generation sequencing (NGS) of three cases identified mutations in a few genes known to be altered in low-grade gliomas, (e.g., BCOR, BCORL1, ERBB3, MYB, and ATM), but no recurrent mutations were seen (Bale et al., 2016). The gene discussed is ERBB3; the disease is central nervous system cancer.